Pulmonary (Lung/Respiratory Tract) Disease
Show Only Open Trials
1.
A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
- Study Status: Open to Enrollment
- Sponsor: ACTG
- Protocol ID: A5295
2.
The Natural History of Gene Expression in Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
3.
Evaluation of the Lungs of Normal (Smokers, Ex-smokers, Non-Smokers) Individuals with Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing, and Bronchial Wall Biopsy
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
4.
5.
PANTHER Study (Prednisone, Azathioprine, and N-acetylcysteine: A Study That Evaluates Response in IPF)
- Study Status: Closed to Enrollment
- Sponsor: IPFnet/NIH
- Disease Status and/or Stage: Idiopathic Pulmonary Fibrosis (IPF)
6.
ACE-IPF Study (AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis)
- Study Status: Closed to Enrollment
- Sponsor: IPFnet/NIH
- Disease Status and/or Stage: Idiopathic Pulmonary Fibrosis (IPF)
7.
Modulation of Arachidonic Acid Metabolism by Chemopreventive Agents in Smokers
- Study Status: Closed to Enrollment
- Sponsor: National Cancer Institute/Division of Cancer Prevention (NCI/DCP)
